Ultrasound artificial intelligence (AI) software developer DiA Imaging Analysis has garnered $14 million in funding from new and existing investors.
The Israel-based company said it would use the new capital to expand its portfolio of AI-based ultrasound offerings and to pursue new and expanded partnerships with ultrasound vendors, PACS/healthcare IT vendors, resellers, and distributors. It also aims to grow its presence in Asia, Europe, and the U.S.
In other DiA news, the firm has appointed Fujifilm SonoSite chief medical officer Dr. Diku Mandavia as an industry board member on its board of directors.